Alnylam Pharmaceuticals, Inc.

Susquehanna Portfolio Strategies, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

5,005

Value ($000)

1,990

Weight

0.0%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,990	0.0%	5,005	12/31/2025
2025 Q3	11/14/2025	2,282	0.0%	5,005	9/30/2025
2025 Q2	8/14/2025	1,632	0.0%	5,005	6/30/2025